SAN FRANCISCO, Jan 13 (Reuters) - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug industry increases its use of artificial intelligence to accelerate the discovery of new drugs.
The companies did not disclose financial terms. In a press release, Modella AI said its "foundation models" and AI agents would be integrated into oncology research and development to support clinical development and biomarker discovery.
"Oncology drug development is becoming more complex, more data-rich and more time-sensitive," said Gabi Raia, Modella AI's chief commercial officer, adding that joining AstraZeneca would allow it to deploy its tools in global trials and clinical settings.
AstraZeneca said that this was the first acquisition of an AI firm by a big pharmaceutical company.
In an interview at the JP Morgan Healthcare Conference, AstraZeneca Chief Financial Officer Aradhana Sarin said the acquisition would "supercharge" the company's quantitative pathology and biomarker discovery efforts by bringing more data and AI capabilities in-house.
The deal was one of a number of pacts between major drug firms and AI companies that were unveiled at the healthcare conference, including a $1 billion collaboration between Nvidia and Eli Lilly. They plan to build a new research lab using Nvidia's latest-generation AI chips.
Modella will accelerate AstraZeneca’s efforts to make pathology more quantitative - using computers to analyze biopsies for relevant proteins and correlate them with clinical data - so AstraZeneca can develop “highly targeted biomarkers and then highly targeted therapeutics,” Sarin said.
The deal is an expansion of a multi-year collaboration that the companies unveiled in July.
Sarin said that partnership served as a "test drive," adding that AstraZeneca ultimately wanted Modella's data, foundation models and AI talent in-house.
She said AI tools could be used to more rapidly select patients for drug trials, which could increase the odds of clinical success and cut related costs.
(Reporting by Maggie Fick; Editing by Thomas Derpinghaus)
LATEST POSTS
- 1
Surging measles cases are 'fire alarm' warning that other diseases could be next - 22026 will be the year NASA astronauts fly around the moon again — if all goes to plan
- 3Revvity says it will exceed 2025 profit forecast range
- 4Hilary Duff's husband responds to Ashley Tisdale's 'toxic' mom group claims: The drama, explained
- 5David Duchovny's new thriller has him stripping down at 65. But its chilling premise hits close to home.
- The Best Cell phone Brands for Tech Aficionados
- Most normal matter in the universe isn't found in planets, stars or galaxies – an astronomer explains where it's distributed
- Step by step instructions to Recognize the Distinction Between Lab Jewels and Precious stone Simulants
- 10 Demonstrated Tips to Dominate Video Altering on Your Cell phone in 2023
- Hezbollah claims right to respond to killing of top commander
- Track down the Ideal Weight reduction Methodology for Your Way of life
- Empathy and reasoning aren’t rivals – new research shows they work together to drive people to help more
- Mississippi Insight for Jan. 11, 2026
- Fire Allegedly Triggered by Wedding Cake Sparkler Causes Venue to Go Up in Flames, Leaving Groom with Second-Degree Burns
